-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VcvcDF8BzRxqdIZprN2RTxE3m7DFop8xAygXVudjGa6lNk6Z3RxEr98kKHCminDN 8yuNjHi0s8bQMx7u/eGq6w== 0000950133-02-000526.txt : 20020414 0000950133-02-000526.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950133-02-000526 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020214 GROUP MEMBERS: BB BIOTECH AG GROUP MEMBERS: BIOTECH TARGET N.V. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADOLOR CORP CENTRAL INDEX KEY: 0001076167 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311429198 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60253 FILM NUMBER: 02549452 BUSINESS ADDRESS: STREET 1: 620 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 MAIL ADDRESS: STREET 1: 620 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 SC 13G/A 1 w57602dsc13ga.txt AMENDMENT #1 TO SC 13G FOR ADOLOR CORPORATION ------------------------------ OMB APPROVAL ------------------------------ OMB Number: 3235-0145 ------------------------------ Expires: October 31, 2002 ------------------------------ Estimated average burden hours per response. . . 14.9 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* ADOLOR CORPORATION ----------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $.0001 PER SHARE ----------------------------------------------------------- (Title of Class of Securities) 00724X102 -------------------------------------------- (CUSIP Number) ------------------------------------------------------ (Date of Event Which Requires Filing This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed " for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 CUSIP No. 00724X102 ------------------ 1. Names of Reporting Persons BB BIOTECH AG ------------------------------------------------------ I.R.S. Identification Nos. of above persons (entities only): N/A -------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [X] (b) [ ] 3. SEC Use Only ------------------------------------------------------------------- 4. Citizenship or Place of Organization SWITZERLAND -------------------------------------------- Number of Shares Beneficially 5. Sole Voting Power 0 Owned by Each Reporting Person -------------------- with: 6. Shared Voting Power 1,742,500 -------------------- 7. Sole Dispositive Power 0 -------------------- 8. Shared Dispositive Power 1,742,500 -------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,742,500 -------------------------------------------------- 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] 11. Percent of Class Represented by amount in Row (9) 5.6% ------------------------------- 12. Type of Reporting Person (See Instructions) HC,CO -------------------------------------
Page 2 of 6 CUSIP No. 00724X102 ------------------ 1. Names of Reporting Persons BIOTECH TARGET N.V. ------------------------------------------------------ I.R.S. Identification Nos. of above persons (entities only): N/A -------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [X] (b) [ ] 3. SEC Use Only ------------------------------------------------------------------- 4. Citizenship or Place of Organization NETHERLANDS ANTILLES -------------------------------------------- Number of Shares Beneficially 5. Sole Voting Power 0 Owned by Each Reporting Person -------------------- with: 6. Shared Voting Power 1,742,500 -------------------- 7. Sole Dispositive Power 0 -------------------- 8. Shared Dispositive Power 1,742,500 -------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,742,500 -------------------------------------------------- 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] 11. Percent of Class Represented by amount in Row (9) 5.6% ------------------------------- 12. Type of Reporting Person (See Instructions) CO -------------------------------------
Page 3 of 6 ITEM 2 2(a) Name of Person Filing: BB BIOTECH AG ("BB BIOTECH"), ON BEHALF OF BIOTECH TARGET N.V. ("BIOTARGET"), ITS WHOLLY-OWNED SUBSIDIARY AND RECORD OWNER OF THE SECURITIES. 2(b) Address of Principal Business Office or, if none, Residence: BB BIOTECH AG: VODERGASSE 3, CH-8300 SCHAFFHAUSEN, SWITZERLAND BIOTECH TARGET N.V.: DE RUYTERKADE 62, WILLEMSTAD, CURACAO, NETHERLANDS ANTILLES 2(c) Citizenship: SEE ITEM NO. 4 OF COVER PAGES -------------------------------------------------- 2(d) Title of Class of Securities COMMON STOCK ---------------------------------- 2(e) CUSIP Number 00724X102 ----------------------------
ITEM 4. OWNERSHIP Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,742,500 ----------------------------------- (b) Percent of class: 5.6% ----------------------------------- (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 0 --------------------- (ii) Shared power to vote or to direct the vote 1,742,500 --------------------- (iii) Sole power to dispose or to direct the disposition of 0 --------------------- (iv) Shared power to dispose or to direct the disposition of 1,742,500 ---------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON. THIS STATEMENT IS FILED JOINTLY BY BB BIOTECH AND BIOTARGET. BIOTARGET IS A WHOLLY OWNED SUBSIDIARY OF BB BIOTECH. Page 4 of 6 ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURES After reasonable inquiry and the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BB BIOTECH AG Date: February 14, 2002 By: /s/ CATHY BRUGGER ----------------- -------------------------- Name: Cathy Brugger -------------------------- Title: Signatory Authority -------------------------- Date: February 14, 2002 By: /s/ RUBINO DI GIROLAMO ----------------- -------------------------- Name: Rubino Di Girolamo -------------------------- Title: Signatory Authority -------------------------- BIOTECH TARGET N.V. Date: February 14, 2002 By: /s/ JAN BOOTSMA ----------------- -------------------------- Name: Jan Bootsma -------------------------- Title: Signatory Authority -------------------------- Date: February 14, 2002 By: /s/ RUBINO DI GIROLAMO ----------------- -------------------------- Name: Rubino Di Girolamo -------------------------- Title: Signatory Authority --------------------------
Page 5 of 6 EXHIBIT INDEX Exhibit A: Agreement by and between BB Biotech and BioTarget with respect to the filing of this disclosure statement. Page 6 of 6 -----END PRIVACY-ENHANCED MESSAGE-----